We are live on ! Find out more
HOOK icon

HOOKIPA Pharma

Delisted

HOOK was delisted on the 7th of August, 2025.

71 hedge funds and large institutions have $115M invested in HOOKIPA Pharma in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 13

82% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 11

51% more capital inflows, than outflows

Capital inflows: $35.6M | Capital outflows: $23.6M

15% more funds holding

Funds holding: 62 → 71 (+9)

3.41% more ownership

Funds ownership: 44.7% → 48.1% (+3.4%)

85% less call options, than puts

Call options by funds: $326K | Put options by funds: $2.18M

Holders
71
Holders Change
+9
Holders Change %
+14.52%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
25
Reduced
13
Closed
11
Calls
$326​K
Puts
$2.18​M
Net Calls
-⁠$1.85​M
Net Calls Change
-⁠$530​K

HOOK Hedge Fund Activity: Q2 2021 in Review

71 of the 5,771 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q2 2021, worth a combined $115M — down 27% from $156M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new HOOK positions and 11 closed out — a net gain of 9 holders — while 25 added to existing stakes and 13 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $5.17M. The largest seller was Fidelity Investments, cutting an estimated $6.97M.

  • 71 institutional investors held HOOKIPA Pharma (HOOK) as of Q2 2021, up from 62 in Q1 2021.
  • Funds reported $115M of HOOKIPA Pharma stock for Q2 2021, down 27% quarter-over-quarter.
  • 20 funds opened new HOOKIPA Pharma positions in Q2 2021 and 11 closed out, a net change of +9 holders.
  • The largest HOOKIPA Pharma buyer in Q2 2021 was Millennium Management, an estimated $5.17M added.
  • The largest HOOKIPA Pharma seller in Q2 2021 was Fidelity Investments, an estimated $6.97M sold.

Based on aggregated 13F filings for Q2 2021.